George Eldridge compensation by year
Protara Therapeutics Summary Compensation Table · all 2 fiscal years held| Component | FY2018 | FY2019 |
|---|---|---|
| Salary | $365,034 | $377,278 |
| Bonus | $0 | $0 |
| Stock awards | $0 | $0 |
| Option awards | $439,380 | $288,028 |
| Non-equity incentive | $142,363 | $151,124 |
| Pension and deferred compensation | $0 | $0 |
| All other | $2,291 | $445,288 |
| Total | $949,068 | $1,261,718 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Protara Therapeutics, Inc. DEF 14A filed April 23, 2020, accession 0001213900-20-009927, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Protara Therapeutics, Inc. filed document, accession 0001213900-20-009927. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2020.
Protara Therapeutics’s named executive officers, FY2019
as the company reported each| Named executive officer | Role | FY2019 total |
|---|---|---|
| Timothy Noyes | Former President, Chief Executive Officer and Director | $1,682,610 |
| George Eldridge · this page | Former Chief Financial Officer | $1,261,718 |
| Steven Burke | Former Chief Medical Officer | $1,002,714 |
| Julio Casoy | Chief Medical Officer | $622,491 |
| Jesse Shefferman | President, Chief Executive Officer and Director | $379,076 |
| Jacqueline Zummo | Senior Vice President, Research Operations | $353,652 |
The full Protara Therapeutics compensation record
free company briefThis page is one person within Protara Therapeutics's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Protara Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.